stars 1 stars 2 stars 3

PreCombTherapeutics AG is a privately held Swiss biotechcompany focused on in vitro cancer diagnostic to improve cancer management. It’s automated microtumor-based 3DTwin™ technology enables clinical institutions to integrate the technology on-site in the hospital. The test makes it possible to functionally evaluate multiple cancer drugs, drug combinations and drug concentrations directly on patient-derived micro-tumors to maximize treatment outcome.

PreComb Questions

The PreComb annual revenue was $5.8 million in 2026.

Olivier Mauti is the Chief Technology Officer and Co-Founder of PreComb.

4 people are employed at PreComb.

PreComb is based in Hombrechtikon, Zurich.

The NAICS codes for PreComb are [54171, 541711, 54, 5417, 541].

The SIC codes for PreComb are [87, 873].

Top PreComb Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users